InvestorsHub Logo
Followers 18
Posts 646
Boards Moderated 0
Alias Born 05/19/2017

Re: None

Tuesday, 10/30/2018 7:53:27 AM

Tuesday, October 30, 2018 7:53:27 AM

Post# of 464918
Aw yeah...full steam ahead!

“...enrolled the first patient in its Phase 2 double-blind, randomized, placebo-controlled, 14-week safety and efficacy trial of ANAVEX®2-73 for the treatment of Parkinson’s disease dementia (PDD).”

Gladdens the heart!

2019: The Year of Anavex
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent AVXL News